Baird analyst Wesley Golladay lowered the firm’s price target on Healthpeak Properties (DOC) to $20 from $21 and keeps an Outperform rating on the shares. The firm updated its model following Q3 results.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DOC:
- Healthpeak Properties, Inc. Earnings Call Insights
- Healthpeak Properties: Strong Q3 Performance and Strategic Positioning Reinforce Buy Rating
- Healthpeak Properties Reports Strong Q3 Leasing Activity
- Healthpeak Properties reports Q3 AFFO 42c, consensus 45c
- Healthpeak Properties backs FY25 AFFO view $1.81-$1.87, consensus $1.83